progress

Morphy Richards Brings “Innovate for Enlightening Progress” to IFA Berlin 2025

BERLIN, Aug. 29, 2025 /PRNewswire/ -- Morphy Richards, a trusted name in home appliances with 89 years of legacy, will…

4 weeks ago

ECOVACS 2024 Sustainability Report Highlights Its Commitment to Sustainability and Data Security

SUZHOU, China, Aug. 28, 2025 /PRNewswire/ -- Recently, ECOVACS (603486.SH), a global leader in service robotics, has outlined its environmental,…

4 weeks ago

PureTech Health plc Half-Year Report

Achieved meaningful progress toward key value inflection points across our diversified portfolio, with multiple programs advancing into or toward late-stage…

4 weeks ago

Praxis Medicines to Present at 36th International Epilepsy Congress 2025 in Lisbon, Showcasing Latest RADIANT Study Data and Leading Precision Epilepsy Pipeline

BOSTON, Aug. 25, 2025 (GLOBE NEWSWIRE) -- Praxis Precision Medicines, Inc. (NASDAQ: PRAX), a clinical-stage biopharmaceutical company focused on developing…

1 month ago

CGTN: A peach blossom village at the heart of Xizang’s transformation

BEIJING, Aug. 18, 2025 /PRNewswire/ -- CGTN published an article highlighting Galai Village, Xizang's "First Peach Blossom Village," and its…

1 month ago

41/2025Trifork Group: Interim report for the quarter and half-year ending 30 June 2025

Company announcement no. 41/2025Schindellegi, Switzerland – 19 August 2025 Interim Financial Report for the three and six months ending 30…

1 month ago

Allarity Therapeutics Provides Second Quarter 2025 Update, Highlighting Clinical Progress, IP Expansion, and New Partnerships

    - Successfully initiated enrollment in advanced Phase 2 ovarian cancer trial - Expanded global IP protection by securing…

1 month ago

Firstsource named a ‘Star Performer’ and a ‘Major Contender’ in Everest Group’s Financial Crime and Compliance (FCC) Operations Services PEAK Matrix Assessment 2025

MUMBAI, India, Aug. 12, 2025 /PRNewswire/ -- Firstsource Solutions Limited (NSE: FSL) (BSE:532809), a leading global provider of specialist domain-led Business Process…

2 months ago

BioNTech Announces Second Quarter 2025 Financial Results and Corporate Update

Continued execution of BioNTech’s oncology strategy with focus on two pan-tumor programs including two announced transactions: mRNA-based cancer immunotherapy candidates…

2 months ago

e& reports 60.7% increase in consolidated net profit, reaching AED 8.8 billion in H1 2025

Q2 consolidated revenue increased to AED 18.0 billion, a 28.1% year-on-year growthQ2 consolidated net profit rises to AED 3.5 billion, backed by…

2 months ago